My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$DD {{ '2015-11-09T14:59:23+0000' | timeago}} • Announcement

Board of directors of $DD, a science and technology-based company, named Edward Breen as the Chairman and CEO, effective immediately, who till date served as Company's Interim Chairman and CEO since Oct. 16, 2015. Prior to joining $DD, Breen served as CEO for $TYC from 2002 to 2012 period.

User Robert Smith {{ '2017-01-24T13:01:54+0000' | timeago}}

$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?

User Charles Elliston {{ '2017-01-23T20:14:24+0000' | timeago}}

A federal judge has upheld the DOJ’s decision to block the $AET-$HUM merger.

User Josh Allan {{ '2017-01-23T20:10:30+0000' | timeago}}

$YHOO is reporting today after market close. Nobody cares about this stock.

User RC xNair {{ '2017-01-23T13:41:30+0000' | timeago}}

Excellent results from $MCD

User Melwyn Jones {{ '2017-01-20T20:15:31+0000' | timeago}}

$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.

$TRV {{ '2017-01-24T13:28:26+0000' | timeago}} • Announcement

Insurance major $TRV reported a 9% increase in its 4Q16 earnings. $TRV's net income increased to $943MM, or $3.28 per share compared to $886MM, or $2.83 per share during the prior year period. Total revenues rose 8% YoverY to $7.19Bil.

$KMB {{ '2017-01-24T13:27:34+0000' | timeago}} • Announcement

$KMB expects 2017 net sales to be similar to 2016, including organic sales growth of about 2%, and EPS of $6.20-6.35. The company predicts adjusted EPS growth of 3-5% compared to $6.03 reported in 2016. Capital spending is expected to be $850-950MM and share repurchases estimated to be $800-1000MM.

$KMB {{ '2017-01-24T13:24:35+0000' | timeago}} • Announcement

$KMB reported a jump in 4Q16 earnings driven by lower costs and expenses. Net income grew to $518MM or $1.40 per share from $344MM or $0.91 per share last year. Net sales rose to $4.544Bil from $4.539Bil. Adjusted EPS increased to $1.45 from $1.42.

$DD {{ '2017-01-24T13:17:28+0000' | timeago}} • Webcast

During 2016, $DD’s GM improved by 60BP. Operating costs declined 11%, including a 41% decline in corporate costs. Operating EPS grew 21%. Segment operating margins improved by about 200BP, with increases in all reportable segments. Capex declined 27% while free cash flow improved by $1.6Bil.

$MMM {{ '2017-01-24T13:16:58+0000' | timeago}} • Announcement

$MMM affirmed its FY17 guidance. The company expects its FY17 earnings to be in the range of $8.45 - 8.80 per share with organic local-cuurency sales growth of 1-3%. The company also expects its free cash flow to be in the range of 95-100%.